Trials / Completed
CompletedNCT03995836
Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients: The EPIMOOSA Study
Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients (EPIMOOSA): Continous Positive Airway Pressure (CPAP) and Bariatric Surgery Impact. EPIMOOSA Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Aragon Institute of Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- —
Summary
This study evaluates epigenetics in morbid obese patients who are waiting for bariatric surgery. A home cardiopulmonary polygraphy is performed to evaluate for the presence of sleep-disordered breathing. The principal investigator make the decision of starting CPAP among patients with obstructive sleep apnea according to current clinical guidelines. One year follow up after bariatric surgery will be performed. A total of 5 visits will be scheduled: two of them before bariatric surgery and 3 after (3, 6 and 12 months). At every visit, all patients had: sleep questionaries, blood samples, EKG-Holter and spirometry are collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CPAP | Decision of CPAP treatment is according to clinical guidelines |
| PROCEDURE | Bariatric Surgery | All patients. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-07-01
- Completion
- 2018-07-01
- First posted
- 2019-06-24
- Last updated
- 2019-06-24
Source: ClinicalTrials.gov record NCT03995836. Inclusion in this directory is not an endorsement.